
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma
Rodrigo Ramella Munhoz, Guilherme Nader Marta, Veridiana Pires de Camargo, et al.
Cancer (2022) Vol. 128, Iss. 24, pp. 4223-4231
Closed Access | Times Cited: 32
Rodrigo Ramella Munhoz, Guilherme Nader Marta, Veridiana Pires de Camargo, et al.
Cancer (2022) Vol. 128, Iss. 24, pp. 4223-4231
Closed Access | Times Cited: 32
Showing 26-50 of 32 citing articles:
Medikamentöse Therapie von malignen Lidtumoren
Daniel Walsch, Olga Furashova, Steffen Emmert, et al.
Augenheilkunde up2date (2024) Vol. 14, Iss. 01, pp. 13-30
Closed Access
Daniel Walsch, Olga Furashova, Steffen Emmert, et al.
Augenheilkunde up2date (2024) Vol. 14, Iss. 01, pp. 13-30
Closed Access
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
Spencer Lessans, Katie A. O’Connell, Jennifer H. Choe
Current Oncology Reports (2024) Vol. 26, Iss. 9, pp. 1120-1133
Open Access
Spencer Lessans, Katie A. O’Connell, Jennifer H. Choe
Current Oncology Reports (2024) Vol. 26, Iss. 9, pp. 1120-1133
Open Access
Efficacy and safety of cemiplimab in cutaneous squamous cell carcinoma on chronic wounds: a French retrospective study
M. Antoszczak, E. Maubec, Ab. Duval-Modeste, et al.
EJC Skin Cancer (2024), pp. 100273-100273
Open Access
M. Antoszczak, E. Maubec, Ab. Duval-Modeste, et al.
EJC Skin Cancer (2024), pp. 100273-100273
Open Access
The state of cancer care in Russia: malignant tumors of the skin (C44). One- and five-years survival of patients, age characteristics. Part II.
Merabishvili Vm, Lev Demidov, А. М. Belyaev, et al.
Pharmacy Formulas (2024) Vol. 6, Iss. 4, pp. 36-50
Closed Access
Merabishvili Vm, Lev Demidov, А. М. Belyaev, et al.
Pharmacy Formulas (2024) Vol. 6, Iss. 4, pp. 36-50
Closed Access
[Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC].
Huaiyong Wang, Yun Han
PubMed (2023) Vol. 26, Iss. 11, pp. 822-832
Closed Access | Times Cited: 1
Huaiyong Wang, Yun Han
PubMed (2023) Vol. 26, Iss. 11, pp. 822-832
Closed Access | Times Cited: 1
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: “Repeat and replicate”
Conor E. Steuer, Nabil F. Saba
Cancer (2022) Vol. 128, Iss. 24, pp. 4177-4178
Closed Access | Times Cited: 1
Conor E. Steuer, Nabil F. Saba
Cancer (2022) Vol. 128, Iss. 24, pp. 4177-4178
Closed Access | Times Cited: 1
Actinic Keratosis, Other Precursors, and Squamous Cell Tumors
Cristina Martinez Zugaib Abdalla, Renato Marchiori Bakos, Luiz Guilherme Cernaglia Aureliano de Lima, et al.
Springer eBooks (2023), pp. 285-313
Closed Access
Cristina Martinez Zugaib Abdalla, Renato Marchiori Bakos, Luiz Guilherme Cernaglia Aureliano de Lima, et al.
Springer eBooks (2023), pp. 285-313
Closed Access